drugset / Trial / NCT02822027

Intravenous Immunoglobin Transfusion in Preterm Infants With Encephalopathy of Prematurity

NCT02822027

Non-randomizedParallel-groupSingle-blindTreatment

Summary

Infection and inflammation is related to increased encephalopathy of prematurities.

Timeline

Start
2016-06-01
Primary completion
2024-12-01
Completion
2024-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Immune Globulin Intravenous (Human) Protein / enzyme biologic
Subject non-human gamma globulin Unknown

Indications

No indication recorded.